EntryPoint Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Sell |
39,025
-1,503
| -4% | -$13.5K | 0.18% | 216 |
|
|
2025
Q1 | $304K | Buy |
+40,528
| New | +$304K | 0.14% | 319 |
|
|
2024
Q4 | – | Sell |
-53,763
| Closed | -$409K | – | 729 |
|
|
2024
Q3 | $409K | Buy |
+53,763
| New | +$409K | 0.23% | 116 |
|
|
2024
Q2 | – | Sell |
-42,679
| Closed | -$217K | – | 918 |
|
|
2024
Q1 | $217K | Buy |
42,679
+37,275
| +690% | +$189K | 0.19% | 92 |
|
|
2023
Q4 | $32.4K | Buy |
+5,404
| New | +$32.4K | 0.03% | 895 |
|